Sponsored Links
| New Lupus Therapy Approval Coincides With Autoimmune Diseases Awareness Month |
 |
 |
 |
| Medical News - Lupus | |||
|
The Food and Drug Administration (FDA) approved Benlysta® (belimumab), a new biologic therapy developed to treat patients suffering from active, autoantibody-positive systemic lupus erythematosus (SLE). This landmark decision heralds the first new therapy developed and approved by the FDA specifically for lupus since 1955. According to Virginia T... Read more: Lupus News From Medical News Today
|